Interaction of annexin A6 with alpha actinin in cardiomyocytes
Tóm tắt
Annexins are calcium dependent phospholipid binding proteins that are expressed in a wide variety of tissues and implicated in various extra- and intracellular processes. In myocardial tissue, annexins A2, A5 and A6 are particularly abundant, of which the expression levels of annexin A6 has been found to be maximal. Conflicting reports from transgenic mice overexpressing annexin A6 or null mice lacking annexin A6 showed imbalances in intracellular calcium turnover and disturbed cardiac contractility. However, few studies have focussed on the signalling module of annexin A6 in the heart either in normal or in pathological state. To identify the putative binding partners of annexin A6 in the heart, ventricular extracts were subjected to glutathione S-transferase (GST)- annexin A6 pull down assay and the GST- annexin A6 bound proteins were identified by mass spectrometry. The pull down fractions of ventricular extracts with GST-full length annexin A6 as well as GST-C terminus deleted annexin A6 when immunoblotted with anti sarcomeric alpha (α)-actinin antibody showed the presence of α-actinin in the immunoblot which was absent when GST-N terminus deleted annexin A6 was used for pull down. Overexpression of green fluorescent protein (GFP) tagged full length annexin A6 showed z-line like appearance in cardiomyocytes whereas GFP-N termimus deleted annexin A6 was mostly localized to the nucleus. Overexpression of GFP-C terminus deleted annexin A6 in cardiomyocytes showed aggregate like appearance in the cytoplasm. Double immunofluorescent staining of cardiomyocytes with anti annexin A6 and anti sarcomeric α-actinin antibodies showed perfect co-localization of these two proteins with annexin A6 appearing like a component of sarcomere. Transient knockdown of annexin A6 in cardiomyocytes by shRNA significantly enhances the contractile functions but does not affect the z-band architecture, as revealed by α-actinin immunostaining in shRNA treated cells. In overall, the present study demonstrated for the first time that annexin A6 physically interacts with sarcomeric α-actinin and alters contractility of cardiomyocytes suggesting that it might play important role in excitation and contraction process.
Tài liệu tham khảo
Rescher U, Gerke V: Annexins-unique membrane binding proteins with diverse functions. J Cell Sci. 2004, 117: 2631-2639. 10.1242/jcs.01245.
Donato R, Russo-Marie F: The annexins: structure and functions. Cell Calcium. 1999, 26: 85-89. 10.1054/ceca.1999.0079.
Benevolensky D, Belikova Y, Mohammadzadeh R, Trouve P, Marotte F, Russo-Marie F, Samuel JL, Charlemagne D: Expression and localization of annexins II, V, and VI in myocardium from patients with end-stage heart failure. Lab Invest. 2000, 80 (2): 123-33.
Camors E, Monceau V, Charlemagne D: Annexins and Ca2+ handling in the heart. Cardiovasc Res. 2005, 65: 793-802.
Iida H, Hatate T, Shibata Y: Immunocytochemical localization of 67 kD Ca2+-binding protein (p67) in ventricular, skeletal, and smooth muscle cells. J Histochem Cytochem. 1992, 40: 1899-1907.
Jans SWS, van Bilsen M, Reutelingsperger CPM, Borgers M, de Jong YF, van der Vusse GJ: Annexin V in the adult rat heart: Isolation, location and quantitation. J Mol Cell Cardiol. 1995, 27: 335-348.
Trouve P, Legot S, Belikova I, Marotte F, Benevolensky D, Russo-Marie F, Samuel JL, Charlemagne D: Localization and quantification of cardiac annexins II, V and VI in hypertensive guinea pigs. Am J Physiol. 1999, 276: H1159-H1166.
Doubell AF, Lazure C, Charbonneau C, Thibault G: Identification and immunolocalization of annexins V and VI, the major cardiac annexins, in rat heart. Cardiovasc Res. 1993, 27: 1359-1367.
Luckcuck T, Trotter PJ, Walker JH: Localization of annexin VI in the adult and neonatal heart. Cell Biol Int. 1998, 22: 199-205.
Grewal T, Heeren J, Mewawala D, Schnitgerhans T, Wendt D, Salomon G, Enrich C, Beisiegel U, Jäckle S: Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment. J Biol Chem. 2000, 275: 33806-33813.
Matteo RG, Moravec CS: Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart. Cardiovasc Res. 2000, 45: 961-970.
Gunteski-Hamblin AM, Song G, Walsh RA, Frenzke M, Boivin GP, Dorn GW, Kaetzel MA, Horseman ND, Dedman JR: Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am J Physiol. 1996, 270: H1091-H1100.
Song G, Campos B, Wagoner LE, Dedman JR, Walsh RA: Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end -stage heart failure. J Mol Cell Cardiol. 1998, 30: 443-451.
Song G, Harding SE, Duchen MR, Tunwell R, Gara PO, Moss SE: Altered mechanical properties and intracellular calcium signaling in cardiomyocytes from annexin 6 null-mutant mice. FASEB J. 2002, 16: 622-624.
Raynal P, Pollard HB: Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochem Biophys Acta. 1994, 1197: 63-93.
Fukami K, Furuhashi K, Inagaki M, Endo T, Hatano S: Requirement of phosphatidylinositol 4, 5-bisphosphate for actinin function. Nature. 1992, 359: 150-152.
Frank D, Kuhn C, Katus HA, Frey N: The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med. 2006, 84: 446-468.
Watanabe T, Inui M, Chen BY, Iga M, Sobue K: Annexin VI-binding proteins in brain. Interaction of annexin VI with a membrane skeletal protein, calspectin (brain spectrin or fodrin). J Biol Chem. 1994, 269: 17656-17662.
Locate S, Colyer J, Gawler DJ, Walker JH: Annexin A6 at the cardiac myocyte sarcolemma - evidence for self-association and binding to actin. Cell Biol Int. 2008, 32: 1388-1396.
Shin DW, Ma J, Kim DH: The asp-rich region at the carboxy terminus of calsequestrin binds to Ca2+ and interacts with triadin. FEBS Lett. 2000, 486: 178-182.
Luo J, Hill BG, Gu Y, Cai J, Srivastava S, Bhatnagar A, Prabhu SD: Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am J Physiol Heart Circ Physiol. 2007, 293: H3673-H3684.
De K, Ghosh G, Datta M, Konar A, Bandyopadhyay J, Bandyopadhyay D, Bhattacharya S, Bandyopadhyay A: Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray. J Endocrinol. 2004, 182: 303-314. 10.1677/joe.0.1820303.
Schröder B, Hasilik A: A protocol for combined delipidation and subfractionation of membrane proteins using organic solvents. Analytical Biochemistry. 2006, 357: 144-146.
Piper HM, Schwartz P, Hutter JF, Spieckermann PG: Energy metabolism and enzyme release of cultured rat heart muscle cells during anoxia. J Mol Cell Cardiol. 1984, 16: 995-1007.
Jeong D, Kim JM, Cha H, Oh JG, Park J, Yun SH, Ju ES, Jeon ES, Hajjar RJ, Park WJ: PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signalling. Circ Res. 2008, 102: 711-719.
Cha H, Kim JM, Oh JG, Jeong MH, Park CS, Park J, Jeong HJ, Park BK, Lee YH, Jeong D, Yang DK, Bernecker OY, Kim do H, Hajjar RJ, Park WJ: PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. J Mol Cell Cardiol. 2008, 6: 796-803. 10.1016/j.yjmcc.2008.09.124.